A considerable amount of research has shown that PPARγ ligands suppress theproliferation rates of many types of cancer cells, particularly those derivedfrom liposarcoma, colon cancer, breast cancer, prostate cancer, myeloidleukemia, glioblastoma, and many others. This evidence concerns the gene PPARG and Familial prostate cancer.